Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

by Cyrus Huneycutt | Nov 14, 2023 | 0 comments

Submit a Comment Cancel reply

You must be logged in to post a comment.